Prostate Cancer Not More Common in Hemophiliacs

renal-and-urology-news

Prostate Cancer Not More Common in Hemophiliacs

 

hs-pc-01

Jody A. Charnow, Editor

February 03, 2015

NEWS IN BRIEF

 

Prostate Cancer Not More Common in Hemophiliacs

hs-pc-02
Hemophilia patients have a higher incidence of cancers, but not prostate cancer.

Patients with hemophilia have a higher incidence of cancers overall compared with the general population, but notprostate cancer (PCa), according to a new study.

Yung-Chieh Huang, MD, of the Taichung Veterans General Hospital in Taichung, Taiwan, and colleagues looked at the incidence of various cancers and associated survival among 1,054 patients with hemophilia and 10,540 age-and gender-matched healthy individuals from the general population. The cumulative incidences of cancer were 4.7% among the patients with hemophilia and 1.9% in the general population, the researchers reported online ahead of print in theAmerican Journal of Hematology. The investigators found no significant differences between the 2 groups in the incidences of PCa, lung, or colorectal cancer or in survival rate.

Hepatocellular carcinoma was the major type of cancer observed in the hemophiliacs, occurring in 17 patients.

Compared with the general population, patients with hemophilia were significantly younger at the time of cancer diagnosis (45.1 vs. 57.2 years old) and had fewer comorbidities.

 

RELATED

hs-pc-03

PCa Family History Screening May Decrease Mortality

 

hs-pc-04

Quarter of Metastatic PCa Patients Had Synchronous Cancer

 

hs-pc-05

Prostate Cancer Linked to Increased Colorectal Cancer Risk

 

hs-pc-06

Important Prostate Cancer Advances of the Last 10 Years

 

hs-pc-07

Biologic agents associated with high risk of hepatitis B virus flares in patients with psoriasis or rheumatoid arthritis

 

hs-pc-08

Biologic Agents Associated with High Risk of HBV Flares in Psoriasis, Other Conditions

 

hs-pc-09

RA, Psoriasis Medications May Increase Risk of Hepatitis B Flares

 

hs-pc-10

Big Data, Big Psychiatry — Big Potential?

 

 

RELATED ARTICLES

 

RELATED TOPICS

 

RELATED LINKS

 

RELATED SLIDESHOWS

hs-pc-11

Is “Fusion” Technology Heralding the “Anatomic” Age for Prostate ….

 

 

hs-pc-12

XOFIGO® (radium Ra 223 dichloride)